Starna Therapeutics Funding: $66M Raised, Series B (2025)
Starna Therapeutics is based in Suzhou, China. It has raised $66M in total funding. Latest round: Series B.
Starna Therapeutics funding overview
Starna Therapeutics is based in Suzhou, China. Starna Therapeutics has raised $66M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in October 2025. The round record for Starna Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include LYFE Capital, Hillhouse Investment, Lilly Asia Ventures, Hony Capital, Source Code Capital, Primavera Venture Partners and 1 others. 7 distinct backers are named across the disclosed rounds.
Frequently asked about Starna Therapeutics funding
How much has Starna Therapeutics raised?
Starna Therapeutics has raised $66M in total disclosed funding across the rounds on record.
Who has invested in Starna Therapeutics?
LYFE Capital, Hillhouse Investment, Lilly Asia Ventures, Hony Capital, Source Code Capital, Primavera Venture Partners are named among the investors backing Starna Therapeutics.
What was the latest Starna Therapeutics funding round?
The most recent disclosed round is a Series B, announced in October 2025.
Where is Starna Therapeutics based?
Starna Therapeutics is based in Suzhou, China.
When did Starna Therapeutics last raise?
The last disclosed Starna Therapeutics round closed in October 2025 at Series B.
Every Starna Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Suzhou at a similar stage.
